U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C3H7O4S2.Au
Molecular Weight 368.182
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AUROTIOPROL ACID

SMILES

[Au+].OC(CS)CS([O-])(=O)=O

InChI

InChIKey=ULXIRCUSBPAVNN-UHFFFAOYSA-M
InChI=1S/C3H8O4S2.Au/c4-3(1-8)2-9(5,6)7;/h3-4,8H,1-2H2,(H,5,6,7);/q;+1/p-1

HIDE SMILES / InChI
Molecular Formula C3H7O4S2
Molecular Weight 171.215
Charge -1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )
Molecular Formula Au
Molecular Weight 196.966569
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Aurotioprol acid is a gold salt. It was used as an antirheumatic agent and marketed by Solvay under tradename Allochrysine. Aurotioprol was administered by intramuscular injections.

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Rat anti-glomerular basement membrane antibodies in toxin-induced autoimmunity and in chronic graft-vs.-host reaction share recurrent idiotypes.
1990-01
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:31:45 GMT 2025
Edited
by admin
on Mon Mar 31 21:31:45 GMT 2025
Record UNII
DW729GNC8E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AURATE(1-), (2-HYDROXY-3-MERCAPTO-1-PROPANESULFONATO(2-)-O2,S3)-, HYDROGEN
Preferred Name English
AUROTIOPROL ACID
Common Name English
Code System Code Type Description
FDA UNII
DW729GNC8E
Created by admin on Mon Mar 31 21:31:45 GMT 2025 , Edited by admin on Mon Mar 31 21:31:45 GMT 2025
PRIMARY
CAS
80501-68-4
Created by admin on Mon Mar 31 21:31:45 GMT 2025 , Edited by admin on Mon Mar 31 21:31:45 GMT 2025
PRIMARY
PUBCHEM
71587296
Created by admin on Mon Mar 31 21:31:45 GMT 2025 , Edited by admin on Mon Mar 31 21:31:45 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966